Epigen Intimate Spray 0.1%, 60 ml per bottle.
Ingredients
Active ingredient: glycyrrhizic acid;
1 g of spray contains 1 mg of glycyrrhizic acid;
Inactive ingredients: maleic acid, fumaric acid, ascorbic acid, folic acid, polysorbate, propylene glycol, purified water.
Dosage Form
Spray.
Main physical and chemical properties: a yellow solution with a characteristic odor.
Pharmacotherapeutic group
Antiviral agents. ATC code D06B B.
Pharmacological properties
Pharmacodynamics.
The active ingredient in Epigen Intimate is glycyrrhizic acid, which is obtained by extraction from plant materials (licorice root).
Glycyrrhizic acid has a complex effect, including immunostimulatory, antiviral, anti-inflammatory, and regenerative effects.
The immunostimulatory effect manifests as an increase in the number and activity of T-lymphocytes, a decrease in the concentration of immunoglobulin G, and an increase in the concentration of immunoglobulin A and immunoglobulin M.
Glycyrrhizic acid induces the production of interferon, which is one of the components of its antiviral action.
Glycyrrhizic acid exerts antiviral activity against various types of RNA and DNA viruses in vitro and in vivo (Varicella Zoster, herpes simplex virus types I and II, cytomegalovirus, and various types of human papillomaviruses). Glycyrrhizic acid interrupts viral replication in the early stages, causing the virion to be released from the capsid, thereby preventing its entry into cells.
Glycyrrhizic acid inactivates these viruses at concentrations that are non-toxic to normally functioning cells. Mutant strains of viruses resistant to acyclovir and ioduridine are just as sensitive to glycyrrhizic acid as non-mutant strains.
Pharmacokinetics.
When applied topically or intravaginally, glycyrrhizic acid is deposited in the superficial (epidermal) layers of the mucous membranes and skin. Systemic absorption occurs slowly. It is present in the blood in trace amounts.
Indications
- Treatment of human papillomavirus (HPV) infection.
- Treatment of viral infections caused by herpes simplex virus types I and II.
- Treatment of viral infections caused by the varicella-zoster virus (shingles) as part of a comprehensive treatment regimen.
- Prevention of recurrences of viral infections caused by herpes simplex virus types I and II, varicella-zoster virus, and human papillomavirus.
- Treatment of nonspecific colpitis and vaginitis (as part of a comprehensive treatment regimen).
Contraindications
Hypersensitivity to any of the drug’s components.
Interactions with Other Medications and Other Types of Interactions
No interactions have been identified with the main classes of drugs used in the comprehensive treatment of the aforementioned conditions (antibiotics and antiseptics, anti-inflammatory agents, and analgesics).
Synergistic effects have been observed with the concurrent use of activated glycyrrhizic acid and other antiviral drugs, particularly acyclovir derivatives, interferon, and other immunomodulators.
Usage Instructions
Rinse the nozzle with boiling water and soap and store it in the enclosed plastic container. The nozzle’s design ensures uniform irrigation of the cervix and vaginal walls. In a hospital setting, intravaginal irrigation using the medication with a speculum can be performed without the nozzle.
Preliminary rinsing of the application site is not required for the medication to be effective.
If signs of intolerance appear, discontinue use of the product.
Use during pregnancy or while breastfeeding.
Contraindicated during the first trimester of pregnancy. During the second and third trimesters, the medication should be used only when, in the physician’s opinion, the expected benefit to the mother outweighs the potential risk to the fetus or infant.
Effect on reaction time when operating vehicles or other machinery.
No effect.
Route of administration and dosage
Topical, intravaginal, and intraurethral administration.
Shake the bottle before use.
Hold the bottle upright when using.
For external use on adults and children over 1 year of age, apply the product to the entire affected area of the skin by spraying from a distance of 4–5 cm, pressing the valve 1–2 times, which is the optimal therapeutic dose.
For intravaginal use in women, a special nozzle with a spray attachment is provided. Remove the spray valve and attach the nozzle. Insert the nozzle into the vagina and press the nozzle 1–2 times, which is the optimal therapeutic dose.
When used by men, in addition to external application, the medication should be administered into the external opening of the urethra by pressing the spray valve 1–2 times. The course of treatment is determined by a doctor depending on the nature and course of the disease.
Children.
Not recommended for use in children under 1 year of age.
Overdose
None reported.
Side Effects
Allergic reactions, skin redness, itching, contact dermatitis.
Shelf life
3 years.
Storage conditions
Store at a temperature not exceeding 20 °C, out of the reach of children.
Packaging
15 mL or 60 mL in a plastic bottle; 1 spray bottle in a cardboard box.
Dispensing Category
Over-the-counter.
Manufacturer
- BROWN MEDICAL S.A.
Address
Ronda de Los Olivares, Lot 11, Los Olivares Industrial Park, Jaén 23009 (Jaén), Spain.
Similar products
Products from the same category










